| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020364362 |
| P356 | DOI | 10.1007/S00415-014-7506-5 |
| P698 | PubMed publication ID | 25236654 |
| P50 | author | Domenico Plantone | Q56944467 |
| Tatiana Koudriavtseva | Q59661369 | ||
| P2093 | author name string | Rosaria Renna | |
| P2860 | cites work | Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study | Q33303065 |
| Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. | Q33851359 | ||
| Systemic complement profiling in multiple sclerosis as a biomarker of disease state. | Q36971983 | ||
| Rheological and fibrinolytic findings in multiple sclerosis | Q37009018 | ||
| Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study | Q39554013 | ||
| Coagulation status and biochemical and inflammatory markers in multiple sclerosis | Q46765835 | ||
| Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients | Q48162703 | ||
| Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication | Q48381265 | ||
| Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome? | Q50702531 | ||
| Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. | Q51984648 | ||
| Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder. | Q54767444 | ||
| Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis | Q57602063 | ||
| High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory–thrombotic processes | Q59154928 | ||
| [The role of hemostasis system in the pathogenesis and course of multiple sclerosis] | Q73853215 | ||
| Normal plasma antithrombin activity in patients with relapsing-remitting and secondary progressive multiple sclerosis | Q83235923 | ||
| Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis | Q88213767 | ||
| P433 | issue | 10 | |
| P921 | main subject | neuromyelitis optica | Q611458 |
| biomarker | Q864574 | ||
| P304 | page(s) | 2028-2029 | |
| P577 | publication date | 2014-09-19 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders | |
| P478 | volume | 261 |
| Q61448811 | A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis |
| Q37472186 | Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations. |
| Q35211902 | Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors. |
| Q43113841 | Quantified CSF antibody reactivity against myelin in multiple sclerosis |
Search more.